{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:11:55Z","timestamp":1790802715246,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    New strategies are needed to counter the escalating threat posed by drug-resistant fungi. The molecular chaperone Hsp90 affords a promising target because it supports survival, virulence and drug-resistance across diverse pathogens. Inhibitors of human Hsp90 under development as anticancer therapeutics, however, exert host toxicities that preclude their use as antifungals. Seeking a route to species-selectivity, we investigate the nucleotide-binding domain (NBD) of Hsp90 from the most common human fungal pathogen,\n                    <jats:italic>Candida albicans<\/jats:italic>\n                    . Here we report structures for this NBD alone, in complex with ADP or in complex with known Hsp90 inhibitors. Encouraged by the conformational flexibility revealed by these structures, we synthesize an inhibitor with\u2009&gt;25-fold binding-selectivity for fungal Hsp90 NBD. Comparing co-crystals occupied by this probe vs. anticancer Hsp90 inhibitors revealed major, previously unreported conformational rearrangements. These insights and our probe\u2019s species-selectivity in culture support the feasibility of targeting Hsp90 as a promising antifungal strategy.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-08248-w","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T06:05:12Z","timestamp":1548309912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus"],"prefix":"10.1038","volume":"10","author":[{"given":"Luke","family":"Whitesell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Shekhar-Guturja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle V.","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine S.","family":"Nation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharanya","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Trilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin L.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian J.","family":"Krysan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John A.","family":"Porco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Tatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-484X","authenticated-orcid":false,"given":"Lauren E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-518X","authenticated-orcid":false,"given":"Juan","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah E.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"8248_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1126\/science.1222236","volume":"336","author":"GD Brown","year":"2012","unstructured":"Brown, G. D., Denning, D. W. & Levitz, S. M. Tackling human fungal infections. Science 336, 647 (2012).","journal-title":"Science"},{"key":"8248_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller, M. A. & Diekema, D. J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20, 133\u2013163 (2007).","journal-title":"Clin. Microbiol. Rev."},{"key":"8248_CR3","doi-asserted-by":"publisher","unstructured":"Robbins, N., Wright, G. D. & Cowen, L. E. Antifungal drugs: the current armamentarium and development of new agents. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.FUNK-0002-2016\u00a0(2016).","DOI":"10.1128\/microbiolspec.FUNK-0002-2016"},{"key":"8248_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.aap7999","volume":"360","author":"MC Fisher","year":"2018","unstructured":"Fisher, M. C., Hawkins, N. J., Sanglard, D. & Gurr, S. J. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 360, 739\u2013742 (2018).","journal-title":"Science"},{"key":"8248_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.mib.2013.03.005","volume":"16","author":"LE Cowen","year":"2013","unstructured":"Cowen, L. E. The fungal Achilles\u2019 heel: targeting Hsp90 to cripple fungal pathogens. Curr. Opin. Microbiol. 16, 377\u2013384 (2013).","journal-title":"Curr. Opin. Microbiol."},{"key":"8248_CR6","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1126\/science.1118370","volume":"309","author":"LE Cowen","year":"2005","unstructured":"Cowen, L. E. & Lindquist, S. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309, 2185\u20132189 (2005).","journal-title":"Science"},{"key":"8248_CR7","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1073\/pnas.0813394106","volume":"106","author":"LE Cowen","year":"2009","unstructured":"Cowen, L. E. et al. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc. Natl Acad. Sci. USA 106, 2818\u20132823 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8248_CR8","doi-asserted-by":"publisher","first-page":"e1000532","DOI":"10.1371\/journal.ppat.1000532","volume":"5","author":"SD Singh","year":"2009","unstructured":"Singh, S. D. et al. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog. 5, e1000532 (2009).","journal-title":"PLoS Pathog."},{"key":"8248_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrm2918","volume":"11","author":"M Taipale","year":"2010","unstructured":"Taipale, M., Jarosz, D. F. & Lindquist, S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat. Rev. Mol. Cell Biol. 11, 515\u2013528 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"8248_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1371\/journal.ppat.1001069","volume":"6","author":"SL LaFayette","year":"2010","unstructured":"LaFayette, S. L. et al. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathog. 6, 79\u201380 (2010).","journal-title":"PLoS Pathog."},{"key":"8248_CR11","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.celrep.2018.04.084","volume":"23","author":"T Caplan","year":"2018","unstructured":"Caplan, T. et al. Functional genomic screening reveals core modulators of echinocandin stress responses in Candida albicans. Cell Rep. 23, 2292\u20132298 (2018).","journal-title":"Cell Rep."},{"key":"8248_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cub.2009.03.017","volume":"19","author":"RS Shapiro","year":"2009","unstructured":"Shapiro, R. S. et al. Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr. Biol. 19, 621\u2013629 (2009).","journal-title":"Curr. Biol."},{"key":"8248_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/ng.605","volume":"42","author":"SM Noble","year":"2010","unstructured":"Noble, S. M., French, S., Kohn, L. A., Chen, V. & Johnson, A. D. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 42, 590\u2013598 (2010).","journal-title":"Nat. Genet."},{"key":"8248_CR14","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1038\/ncomms7741","volume":"6","author":"TR O\u2019Meara","year":"2015","unstructured":"O\u2019Meara, T. R. et al. Global analysis of fungal morphology exposes mechanisms of host cell escape. Nat. Commun. 6, 6741 (2015).","journal-title":"Nat. Commun."},{"key":"8248_CR15","doi-asserted-by":"publisher","first-page":"e1002257","DOI":"10.1371\/journal.ppat.1002257","volume":"7","author":"N Robbins","year":"2011","unstructured":"Robbins, N. et al. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 7, e1002257 (2011).","journal-title":"PLoS Pathog."},{"key":"8248_CR16","doi-asserted-by":"publisher","first-page":"18297","DOI":"10.1073\/pnas.1421323111","volume":"111","author":"L Whitesell","year":"2014","unstructured":"Whitesell, L. et al. HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models. Proc. Natl Acad. Sci. USA 111, 18297\u201318302 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8248_CR17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.tim.2017.05.003","volume":"25","author":"TR O\u2019Meara","year":"2017","unstructured":"O\u2019Meara, T. R., Robbins, N. & Cowen, L. E. The Hsp90 chaperone network modulates candida virulence traits. Trends Microbiol. 25, 809\u2013819 (2017).","journal-title":"Trends Microbiol."},{"key":"8248_CR18","doi-asserted-by":"publisher","first-page":"8324","DOI":"10.1073\/pnas.91.18.8324","volume":"91","author":"L Whitesell","year":"1994","unstructured":"Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E. & Neckers, L. M. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl Acad. Sci. USA 91, 8324\u20138328 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8248_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1021\/jm980403y","volume":"42","author":"SM Roe","year":"1999","unstructured":"Roe, S. M. et al. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 42, 260\u2013266 (1999).","journal-title":"J. Med. Chem."},{"key":"8248_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc1716","volume":"5","author":"L Whitesell","year":"2005","unstructured":"Whitesell, L. & Lindquist, S. L. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 5, 761\u2013772 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"8248_CR21","doi-asserted-by":"crossref","unstructured":"Ochiana, S. O., Taldone, T. & Chiosis, G. in The Molecular Chaperones Interaction Networks in Protein Folding and Degradation Vol. 1 (ed. Houry, W.A.) 151\u2013183 (Springer, New York, NY, 2014).","DOI":"10.1007\/978-1-4939-1130-1_7"},{"key":"8248_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1517\/13543776.2014.887681","volume":"24","author":"T Taldone","year":"2014","unstructured":"Taldone, T., Patel, H. J., Bolaender, A., Patel, M. R. & Chiosis, G. Protein chaperones: a composition of matter review (2008-2013). Expert Opin. Ther. Pat. 24, 501\u2013518 (2014).","journal-title":"Expert Opin. Ther. Pat."},{"key":"8248_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1517\/13543784.2014.902442","volume":"23","author":"K Jhaveri","year":"2014","unstructured":"Jhaveri, K. et al. Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions. Expert. Opin. Investig. Drugs 23, 611\u2013628 (2014).","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"8248_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/nsmb.3305","volume":"23","author":"BK Zierer","year":"2016","unstructured":"Zierer, B. K. et al. Importance of cycle timing for the function of the molecular chaperone Hsp90. Nat. Struct. Mol. Biol. 23, 1020\u20131028 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"8248_CR25","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/pro.2103","volume":"21","author":"CN Cunningham","year":"2012","unstructured":"Cunningham, C. N., Southworth, D. R., Krukenberg, K. A. & Agard, D. A. The conserved arginine 380 of Hsp90 is not a catalytic residue, but stabilizes the closed conformation required for ATP hydrolysis. Protein Sci. 21, 1162\u20131171 (2012).","journal-title":"Protein Sci."},{"key":"8248_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.molcel.2008.10.024","volume":"32","author":"DR Southworth","year":"2008","unstructured":"Southworth, D. R. & Agard, D. A. Species-dependent ensembles of conserved conformational states define the Hsp90 chaperone ATPase cycle. Mol. Cell 32, 631\u2013640 (2008).","journal-title":"Mol. Cell"},{"key":"8248_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm.2017.20","volume":"18","author":"FH Schopf","year":"2017","unstructured":"Schopf, F. H., Biebl, M. M. & Buchner, J. The HSP90 chaperone machinery. Nat. Rev. Mol. Cell Biol. 18, 345\u2013360 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"8248_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2887","volume":"10","author":"J Trepel","year":"2010","unstructured":"Trepel, J., Mollapour, M., Giaccone, G. & Neckers, L. Targeting the dynamic HSP90 complex in cancer. Nat. Rev. Cancer 10, 537\u2013549 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"8248_CR29","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bbamcr.2011.12.006","volume":"1823","author":"L Whitesell","year":"2012","unstructured":"Whitesell, L. & Lin, N. U. HSP90 as a platform for the assembly of more effective cancer chemotherapy. Biochim. Biophys. Acta 1823, 756\u2013766 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"8248_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bmcl.2013.11.036","volume":"24","author":"JT Ernst","year":"2014","unstructured":"Ernst, J. T. et al. Correlation between chemotype-dependent binding conformations of HSP90\u03b1\/\u03b2 and isoform selectivity-Implications for the structure-based design of HSP90\u03b1\/\u03b2 selective inhibitors for treating neurodegenerative diseases. Bioorg. Med. Chem. Lett. 24, 204\u2013208 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"8248_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.chembiol.2004.03.033","volume":"11","author":"L Wright","year":"2004","unstructured":"Wright, L. et al. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms. Chem. Biol. 11, 775\u2013785 (2004).","journal-title":"Chem. Biol."},{"key":"8248_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nprot.2011.305","volume":"6","author":"AM Rossi","year":"2011","unstructured":"Rossi, A. M. & Taylor, C. W. Analysis of protein-ligand interactions by fluorescence polarization. Nat. Protoc. 6, 365\u2013387 (2011).","journal-title":"Nat. Protoc."},{"key":"8248_CR33","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1016\/j.bmcl.2006.06.025","volume":"16","author":"K Moulick","year":"2006","unstructured":"Moulick, K. et al. Synthesis of a red-shifted fluorescence polarization probe for Hsp90. Bioorg. Med. Chem. Lett. 16, 4515\u20134518 (2006).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"8248_CR34","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.1073\/pnas.0602650103","volume":"103","author":"LT Gooljarsingh","year":"2006","unstructured":"Gooljarsingh, L. T. et al. A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues. Proc. Natl Acad. Sci. USA 103, 7625\u20137630 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8248_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jprot.2016.01.016","volume":"136","author":"JR Wisniewski","year":"2016","unstructured":"Wisniewski, J. R., Vildhede, A., Noren, A. & Artursson, P. In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes. J. Proteom. 136, 234\u2013247 (2016).","journal-title":"J. Proteom."},{"key":"8248_CR36","doi-asserted-by":"publisher","first-page":"e2492","DOI":"10.1371\/journal.pntd.0002492","volume":"7","author":"JC Pizarro","year":"2013","unstructured":"Pizarro, J. C. et al. Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design. PLoS Negl. Trop. Dis. 7, e2492 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"8248_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/jm701018h","volume":"51","author":"PA Brough","year":"2008","unstructured":"Brough, P. A. et al. 4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. J. Med. Chem. 51, 196\u2013218 (2008).","journal-title":"J. Med. Chem."},{"key":"8248_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s002800100373","volume":"48","author":"S Soga","year":"2001","unstructured":"Soga, S. et al. Stereospecific antitumor activity of radicicol oxime derivatives. Cancer Chemother. Pharmacol. 48, 435\u2013445 (2001).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"8248_CR39","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1182\/blood.V96.6.2284","volume":"96","author":"Y Shiotsu","year":"2000","unstructured":"Shiotsu, Y. et al. Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex. Blood 96, 2284\u20132291 (2000).","journal-title":"Blood"},{"key":"8248_CR40","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1021\/ol052263+","volume":"7","author":"E Moulin","year":"2005","unstructured":"Moulin, E., Barluenga, S. & Winssinger, N. Concise synthesis of pochonin A, an HSP90 inhibitor. Org. Lett. 7, 5637\u20135639 (2005).","journal-title":"Org. Lett."},{"key":"8248_CR41","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1016\/j.bmc.2009.04.060","volume":"17","author":"H Shinonaga","year":"2009","unstructured":"Shinonaga, H. et al. Synthesis and structure-activity relationships of radicicol derivatives and WNT-5A expression inhibitory activity. Bioorg. Med. Chem. 17, 4622\u20134635 (2009).","journal-title":"Bioorg. Med. Chem."},{"key":"8248_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1021\/np058095b","volume":"69","author":"TJ Turbyville","year":"2006","unstructured":"Turbyville, T. J. et al. Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert. J. Nat. Prod. 69, 178\u2013184 (2006).","journal-title":"J. Nat. Prod."},{"key":"8248_CR43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1104\/pp.107.101808","volume":"145","author":"CA McLellan","year":"2007","unstructured":"McLellan, C. A. et al. A rhizosphere fungus enhances Arabidopsis thermotolerance through production of an HSP90 inhibitor. Plant Physiol. 145, 174\u2013182 (2007).","journal-title":"Plant Physiol."},{"key":"8248_CR44","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature01913","volume":"425","author":"A Kamal","year":"2003","unstructured":"Kamal, A. et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425, 407\u2013410 (2003).","journal-title":"Nature"},{"key":"8248_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature19807","volume":"538","author":"A Rodina","year":"2016","unstructured":"Rodina, A. et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature 538, 397\u2013401 (2016).","journal-title":"Nature"},{"key":"8248_CR46","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nri3897","volume":"15","author":"MG Netea","year":"2015","unstructured":"Netea, M. G., Joosten, L. A., van der Meer, J. W., Kullberg, B. J. & van de Veerdonk, F. L. Immune defence against Candida fungal infections. Nat. Rev. Immunol. 15, 630\u2013642 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"8248_CR47","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1021\/jm401279n","volume":"57","author":"EM Wijeratne","year":"2014","unstructured":"Wijeratne, E. M. et al. Structure-activity relationships for withanolides as inducers of the cellular heat-shock response. J. Med. Chem. 57, 2851\u20132863 (2014).","journal-title":"J. Med. Chem."},{"key":"8248_CR48","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/cb200353m","volume":"7","author":"S Santagata","year":"2012","unstructured":"Santagata, S. et al. Using the heat-shock response to discover anticancer compounds that target protein homeostasis. Acs. Chem. Biol. 7, 340\u2013349 (2012).","journal-title":"Acs. Chem. Biol."},{"key":"8248_CR49","doi-asserted-by":"crossref","unstructured":"Baeder, D. Y., Yu, G., Hoz\u00e9, N., Rolff, J. & Regoes, R. R. Antimicrobial combinations: bliss independence and Loewe additivity derived from mechanistic multi-hit models. Philos. Trans. R. Soc. B 371, 20150294 (2016).","DOI":"10.1098\/rstb.2015.0294"},{"key":"8248_CR50","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.1074\/jbc.M111450200","volume":"277","author":"BAL Owen","year":"2002","unstructured":"Owen, B. A. L., Sullivan, W. P., Felts, S. J. & Toft, D. O. Regulation of heat shock protein 90 ATPase activity by sequences in the carboxyl terminus. J. Biol. Chem. 277, 7086\u20137091 (2002).","journal-title":"J. Biol. Chem."},{"key":"8248_CR51","doi-asserted-by":"publisher","first-page":"11301","DOI":"10.1074\/jbc.M510142200","volume":"281","author":"K Richter","year":"2006","unstructured":"Richter, K. et al. Intrinsic inhibition of the Hsp90 ATPase activity. J. Biol. Chem. 281, 11301\u201311311 (2006).","journal-title":"J. Biol. Chem."},{"key":"8248_CR52","doi-asserted-by":"crossref","unstructured":"Sekhar, A. et al. Conserved conformational selection mechanism of Hsp70 chaperone-substrate interactions. Elife 7, e32764 (2018).","DOI":"10.7554\/eLife.32764"},{"key":"8248_CR53","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.2174\/1568026616666160413141154","volume":"16","author":"DT Gewirth","year":"2016","unstructured":"Gewirth, D. T. Paralog specific Hsp90 inhibitors\u2014a brief history and a bright future. Curr. Top. Med. Chem. 16, 2779\u20132791 (2016).","journal-title":"Curr. Top. Med. Chem."},{"key":"8248_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02013-1","volume":"9","author":"A Khandelwal","year":"2018","unstructured":"Khandelwal, A. et al. Structure-guided design of an Hsp90\u03b2 N-terminal isoform-selective inhibitor. Nat. Commun. 9, 425 (2018).","journal-title":"Nat. Commun."},{"key":"8248_CR55","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1021\/acs.jmedchem.7b01608","volume":"61","author":"NLS Que","year":"2018","unstructured":"Que, N. L. S. et al. Structure based design of a Grp94-selective inhibitor: exploiting a key residue in Grp94 to optimize paralog-selective binding. J. Med. Chem. 61, 2793\u20132805 (2018).","journal-title":"J. Med. Chem."},{"key":"8248_CR56","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1021\/jm500042s","volume":"57","author":"JT Ernst","year":"2014","unstructured":"Ernst, J. T. et al. Identification of novel HSP90alpha\/beta isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington\u2019s disease. J. Med. Chem. 57, 3382\u20133400 (2014).","journal-title":"J. Med. Chem."},{"key":"8248_CR57","doi-asserted-by":"publisher","first-page":"46162","DOI":"10.1074\/jbc.M405253200","volume":"279","author":"RM Immormino","year":"2004","unstructured":"Immormino, R. M. et al. Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone. J. Biol. Chem. 279, 46162\u201346171 (2004).","journal-title":"J. Biol. Chem."},{"key":"8248_CR58","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nchembio.1335","volume":"9","author":"PD Patel","year":"2013","unstructured":"Patel, P. D. et al. Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2. Nat. Chem. Biol. 9, 677\u2013684 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"8248_CR59","doi-asserted-by":"publisher","first-page":"18336","DOI":"10.1074\/jbc.M211309200","volume":"278","author":"G Banumathy","year":"2003","unstructured":"Banumathy, G., Singh, V., Pavithra, S. R. & Tatu, U. Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes. J. Biol. Chem. 278, 18336\u201318345 (2003).","journal-title":"J. Biol. Chem."},{"key":"8248_CR60","doi-asserted-by":"crossref","unstructured":"Neckers, L. et al. Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development. Cell Stress Chaperones 23, 467\u2013482 (2018).","DOI":"10.1007\/s12192-018-0877-2"},{"key":"8248_CR61","doi-asserted-by":"publisher","first-page":"e1001126","DOI":"10.1371\/journal.ppat.1001126","volume":"6","author":"BE Mansfield","year":"2010","unstructured":"Mansfield, B. E. et al. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi. PLoS Pathog. 6, e1001126 (2010).","journal-title":"PLoS Pathog."},{"key":"8248_CR62","doi-asserted-by":"publisher","unstructured":"Prasad, R., Balzi, E., Banerjee, A. & Khandelwal, N. K. All about Candida drug resistance CDRs: past, present and future. Yeast. https:\/\/doi.org\/10.1002\/yea.3356 (2018)","DOI":"10.1002\/yea.3356"},{"key":"8248_CR63","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzym. 276, 307\u2013326 (1997).","journal-title":"Methods Enzym."},{"key":"8248_CR64","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1107\/S1399004714013534","volume":"70","author":"W Kabsch","year":"2014","unstructured":"Kabsch, W. Processing of X-ray snapshots from crystals in random orientations. Acta Crystallogr. D Biol. Crystallogr. 70, 2204\u20132216 (2014).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"8248_CR65","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nsb0697-477","volume":"4","author":"C Prodromou","year":"1997","unstructured":"Prodromou, C., Roe, S. M., Piper, P. W. & Pearl, L. H. A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone. Nat. Struct. Biol. 4, 477\u2013482 (1997).","journal-title":"Nat. Struct. Biol."},{"key":"8248_CR66","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"8248_CR67","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"8248_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"8248_CR69","unstructured":"Zwart, P. H., Grosse-Kunsteleve, R. W. & Adams, P. D. Characterization of X-ray data sets. CCP Newsl. 42, (2005)."},{"key":"8248_CR70","doi-asserted-by":"publisher","first-page":"W375","DOI":"10.1093\/nar\/gkm216","volume":"35","author":"IW Davis","year":"2007","unstructured":"Davis, I. W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375\u2013W383 (2007).","journal-title":"Nucleic Acids Res."},{"key":"8248_CR71","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1107\/S0567739476001873","volume":"32","author":"W Kabsch","year":"1976","unstructured":"Kabsch, W. A solution for the best rotation to relate two sets of vectors. Acta Crystallogr. Sect. A 32, 922\u2013923 (1976).","journal-title":"Acta Crystallogr. Sect. A"},{"key":"8248_CR72","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"8248_CR73","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"8248_CR74","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1021\/acs.jnatprod.7b00918","volume":"81","author":"EMK Wijeratne","year":"2018","unstructured":"Wijeratne, E. M. K. et al. Withaferin A and Withanolide D analogues with dual heat-shock-inducing and cytotoxic activities: semisynthesis and biological evaluation. J. Nat. Prod. 81, 825\u2013837 (2018).","journal-title":"J. Nat. Prod."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08248-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08248-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08248-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T14:32:29Z","timestamp":1671201149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08248-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["8248"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-08248-w","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734925332.793563466","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"22 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.E.C and S.L. are named as inventors on USPTO 8343913. L.W. and L.E.C. are scientific co-founders and stock holders of Bright Angel Therapeutics (BAT), a company pursuing the discovery and development of new antifungals. J.P. is a paid consultant to BAT. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}